These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 79046)

  • 1. Radiological evidence for regression of prolactinoma after treatment with bromocriptine.
    Sobrinho LG; Nunes MC; Santos MA; Mauricio JC
    Lancet; 1978 Jul; 2(8083):257-8. PubMed ID: 79046
    [No Abstract]   [Full Text] [Related]  

  • 2. Conservative management of pituitary prolactinomas; evidence for bromocriptine-induced regression.
    Hancock KW; Scott JS; Lamb JT; Gibson RM; Chapman C
    Br J Obstet Gynaecol; 1980 Jun; 87(6):523-9. PubMed ID: 7397087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of pituitary prolactinoma after treatment with bromocriptine.
    Landolt AM; Wüthrich R; Fellmann H
    Lancet; 1979 May; 1(8125):1082-3. PubMed ID: 86800
    [No Abstract]   [Full Text] [Related]  

  • 4. Growth of prolactinoma despite lowering of serum prolactin by bromocriptine.
    Kupersmith MJ; Kleinberg D; Warren FA; Budzilovitch G; Cooper P
    Neurosurgery; 1989 Mar; 24(3):417-23. PubMed ID: 2927618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid changes of prolactinoma volume after withdrawal and reinstitution of bromocriptine.
    Thorner MO; Perryman RL; Rogol AD; Conway BP; Macleod RM; Login IS; Morris JL
    J Clin Endocrinol Metab; 1981 Sep; 53(3):480-3. PubMed ID: 7263835
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperprolactinaemic amenorrhoea--results of treatment with bromocriptine.
    Bergh T; Nillius SJ; Wide L
    Acta Endocrinol Suppl (Copenh); 1978; 216():147-64. PubMed ID: 347859
    [No Abstract]   [Full Text] [Related]  

  • 7. The occurrence of macroscopical pituitary calcifications in prolactinomas.
    Rasmussen C; Larsson SG; Bergh T
    Neuroradiology; 1990; 31(6):507-11. PubMed ID: 2352634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term bromocriptine treatment of giant prolactinoma: report of a case].
    Mashio Y; Beniko M; Ikota A; Mizumoto H; Sato S; Yamaguchi O; Suzuki S; Tashiro T; Ikota T
    Nihon Naika Gakkai Zasshi; 1989 Dec; 78(12):1785-6. PubMed ID: 2625603
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of bromocriptine on pituitary tumour size.
    McGregor AM; Scanlon MF; Hall R; Hall K
    Br Med J; 1979 Sep; 2(6192):700-3. PubMed ID: 509071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dramatic and rapid shrinkage of a massive invasive prolactinoma with bromocriptine: a case report.
    Clayton RN; Webb J; Heath DA; Dunn PJ; Rolfe EB; Hockley AD
    Clin Endocrinol (Oxf); 1985 May; 22(5):573-81. PubMed ID: 4028456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bromocriptine therapy of prolactinoma in pregnancy].
    Nehmzow M; Ventz M; Meng W
    Zentralbl Gynakol; 1985; 107(14):899-903. PubMed ID: 4036407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient intrasellar collection of air during bromocriptine treatment of a prolactinoma.
    Fagel WJ; Hekster RE; Smith SJ; van der Vijver JC
    Neuroradiology; 1986; 28(4):364-6. PubMed ID: 3762918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immediate efficacy of bromocriptine (BrC)-LAR in the treatment of macroprolactinomas: apropos of a case].
    García Calzado MC; Ruiz Buendía A
    Rev Clin Esp; 1992 Jun; 191(2):112-3. PubMed ID: 1502384
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of the elution pattern of the serum and CSF prolactin fractionated by gel filtration chromatography in cases of bromocriptine-resistant prolactinoma].
    Sakamoto T; Kowada M; Hasegawa H; Ishino Y; Mineura K; Wakisaka A; Fukushima M
    Neurol Med Chir (Tokyo); 1987 Mar; 27(3):195-201. PubMed ID: 2442642
    [No Abstract]   [Full Text] [Related]  

  • 15. Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment.
    Zacharieva S; Stoeva I; Andreeva M; Kalinov K; Matrozov P; Andonova K
    Methods Find Exp Clin Pharmacol; 1996 Nov; 18(9):593-7. PubMed ID: 9010834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Macroprolactinoma resistant to bromocriptine].
    López-Espinosa E; Ayala AR; Grimaldo J; Kunhardt J; Villanueva C
    Arch Invest Med (Mex); 1989; 20(1):1-8. PubMed ID: 2669670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiological control of prolactin adenomas treated with bromocriptine].
    Metzger J; Gardeur D; Pehuet M; Houlbert D
    Ann Med Interne (Paris); 1982; 133(1):59-60. PubMed ID: 7065592
    [No Abstract]   [Full Text] [Related]  

  • 18. A giant prolactinoma and the effect of chronic bromocriptine therapy on basal and TRH-stimulated serum prolactin levels.
    Barrera CM; Ruiz AE; Banks WA
    Horm Res; 1991; 35(3-4):167-9. PubMed ID: 1806471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prolactinoma in men].
    Galvan G; Frick J
    Wien Med Wochenschr; 1983 Aug; 133(15-16):381-5. PubMed ID: 6636796
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure of bromocriptine to maintain reduction in size of a macroprolactinoma.
    Breidahl HD; Topliss DJ; Pike JW
    Br Med J (Clin Res Ed); 1983 Aug; 287(6390):451-2. PubMed ID: 6411170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.